Enteric fever, primarily caused by Salmonella Typhi and Paratyphi, remains a significant health challenge, particularly in developing countries. This article aims to highlight recent advancements and best practices in the management of this disease, providing a comprehensive guide for healthcare professionals.
Accurate and prompt diagnosis of enteric fever is crucial. Conventional culture methods, though gold standard, are time-consuming and lack sensitivity. Advances in molecular diagnostics, such as Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS), offer rapid, sensitive, and specific detection of the causative organisms. These techniques also aid in identifying antibiotic resistance, crucial for effective treatment planning.
Antimicrobial resistance is a pressing concern in enteric fever management. The emergence of extensively drug-resistant (XDR) strains necessitates the use of newer antimicrobials. Azithromycin has shown effectiveness against multi-drug resistant strains, while newer agents like ceftriaxone and carbapenems are used for XDR strains. Vaccination remains a crucial preventative measure, with the newer Typhoid Conjugate Vaccines (TCV) showing promising results in reducing disease incidence.
Best practices include early diagnosis, appropriate use of antimicrobials, and preventive strategies. Clinicians should consider enteric fever in febrile patients with relevant travel or contact history. Empirical therapy should be guided by local antimicrobial resistance patterns. Vaccination, particularly TCV, should be promoted in high-risk populations. Additionally, improving sanitation and safe water supply are essential public health measures.
Managing enteric fever involves a multi-faceted approach, incorporating advancements in diagnostic techniques and treatment modalities. Adherence to best practices, including appropriate antimicrobial use and preventive measures, is crucial. Healthcare professionals play a pivotal role in combating this disease, through timely diagnosis, effective treatment, and patient education on preventive measures.
1.
High Response Rate in Heavily Treated Multiple Myeloma With Novel Drug Combination
2.
Measurable Residual Disease Predicts Real-World AML Relapse
3.
Chemotherapy can be a challenging treatment?here's how to deal with some of the side-effects
4.
Black women are more likely to die of breast cancer. Close the gap by looking into mammogram studies.
5.
Admissions, medical schools, costs, and eligibility requirements information for FNB Head and Neck Oncology.
1.
Modern Developments in Oncology for Specialists
2.
Case-Based Learning: Reasoning Through New Functional Changes During Long-Term Cancer Survivorship
3.
The Latest Advances in Glioblastoma Treatment and Prevention
4.
How is Digital Innovation Revolutionizing Gynecologic Oncology Treatment and Patient Engagement?
5.
Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
2.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
4.
Understanding Iron Deficiency and Its Common Symptoms
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation